Ann Rheum Dis. 2019;78(2):282-284.
Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
제1저자 박진균 · 교신저자 Xavier Mariette
소속 (5)
- Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, Korea.
- Rheumatology Department, Université Paris-Sud, INSERM UMR1184, Immunology of Viral Infections and Autoimmune Diseases, Hôpitaux Universitaires Paris-Sud-Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France.
- Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA.
- Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
- Rheumatology Department, Université Paris-Sud, INSERM UMR1184, Immunology of Viral Infections and Autoimmune Diseases, Hôpitaux Universitaires Paris-Sud-Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France xavier.mariette@aphp.fr.
Keywords
BAFFmethotrexaterheumatoid arthritisvaccination
Conflict of interest statement
Competing interests: EBL has acted as a consultant to Pfizer and received research grants from GC Pharma and Hanmi Pharm.
그 밖의 정보
- 출판 형태
- Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- 저널
- Annals of the rheumatic diseases · eISSN 1468-2060
- 전자 출판
- 2018-10-08
- MeSH
- Arthritis, Rheumatoid / drug therapy / immunology / virology · B-Lymphocytes / drug effects / immunology · Drug Interactions / immunology · Female · Humans · Influenza A virus / immunology · Influenza Vaccines / immunology · Influenza, Human / immunology / prevention & control · Male · Methotrexate / immunology · Middle Aged
- Substances
- Influenza Vaccines · Methotrexate